BBLG Q3 2017 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q3 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$1M

Net Income

-$3M

EPS (Diluted)

$-2199.24

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$561,035

Free Cash Flow

-$561,035

Stock-Based Comp.

$367,157

Balance Sheet

Total Assets

$2M

Total Liabilities

$13M

Stockholders' Equity

-$11M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$1M	-$4M	+70.7%
Net Income	-$3M	-$4M	+42.2%